CAAS Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$1.48M	–	591
2021 Q3	$1.48M	Hold	5,000	–	–	0.03%	177
2021 Q2	$1.62M	Buy	+5,000	New	+$1.62M	0.03%	188